The UKIPO has temporarily reduced or removed certain fees associated with patents, trade marks and registered designs until 31 March 2021.
In light of the disruption caused by Covid-19, the UK Intellectual Property Office (UK IPO) announced a period of interruption which extended certain time periods on patent, trade mark and registered design applications. This period of interruption ended on 29 July 2020.
To further help applicants after the end of the period of interruption, the UK IPO has introduced temporary fee changes taking effect from 30 July 2020 until 31 March 2021.
Under the new temporary fees:
- Official fees for extensions of time will be zero;
- There will be no surcharge for payment of a patent application fee after the date of filing;
- Fees to apply for reinstatement and restoration will be zero;
- For patents and designs, there will be no surcharge for late payment of a renewal fee; and
- For trade marks, the surcharge for late payment of a renewal fee will be £1.
If you would like to find out how these changes could benefit you, please get in touch with your usual Wynne-Jones contact.
For the full news story published by the UK IPO, please click here
Top Cat helps Dibble nab Copy Cats
It’s news that could make Amazon the most tip top Top Cat among toy and game designers, inventors and parents worldwide.
The retailer has announced the establishment of a Counterfeit Crimes Unit that will be tasked with bringing copycats to justice. The Counterfeit Crimes Unit is composed of former federal prosecutors, data analysts and investigators and will be charged with bringing sellers that break not only law, but Amazon’s policies, to justice.
UK Supreme Court judgment: Regeneron v Kymab
On 24 June 2020, the UK Supreme Court handed down its landmark judgment in Regeneron Pharmaceuticals Inc v Kymab Ltd  UKSC 27 in a dispute that has been rumbling on for seven years. It was good news for Kymab and bad news for Regeneron, which saw two of its patents invalidated. For the rest of us, it’s an important case which includes key rulings on insufficiency.
Coronavirus - UK IPO, EPO and EU IPO extensions and support
A simple overview of the current status from IPOs. Last updated 18th May 2020.
Is it unethical to patent?
The Covid-19 pandemic has prompted many companies to invest time and effort in developing technology that is aimed at helping care for, test, or treat people suffering from the disease. In normal times, these might be considered normal commercial activities and would be considered for patenting without a second thought. However, the fact that these developments are typically not being motivated by pure commercial gain, but by a desire to do something for the public good causes many companies to question whether or not they should seeks patents or any other form of intellectual property protection.